FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Phillip Markham

Research Profile

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Sampa Santra; Yue Sun; Jenny G Parvani; Valerie Philippon; Michael S Wyand; Kelledy Manson; Alicia Gomez-Yafal; Gail P Mazzara; Dennis Panicali; Phillip D Markham; David C Montefiori; Norman L Letvin
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.
V Raúl Gómez-Román; George J Grimes; Gopal K Potti; Bo Peng; Thorsten Demberg; Luisa Gravlin; James Treece; Ranajit Pal; Eun Mi Lee; W Gregory Alvord; Phillip D Markham; Marjorie Robert-Guroff
Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques.
Igor M Belyakov; Vladimir Kuznetsov; Brian Kelsall; Dennis M Klinman; Marcin Moniuszko; Michael Lemon; Phillip D Markham; Ranajit Pal; John Clements; Mark G Lewis; Warren Strober; Genoveffa Franchini; Jay A Berzofsky
Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Phillip Markham (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Sampa Santra; Yue Sun; Jenny G Parvani; Valerie Philippon; Michael S Wyand; Kelledy Manson; Alicia Gomez-Yafal; Gail P Mazzara; Dennis Panicali; Phillip D Markham; David C Montefiori; Norman L Letvin
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors.
Journal of virology 2007;81(16):8563-70.
2006: V Raúl Gómez-Román; George J Grimes; Gopal K Potti; Bo Peng; Thorsten Demberg; Luisa Gravlin; James Treece; Ranajit Pal; Eun Mi Lee; W Gregory Alvord; Phillip D Markham; Marjorie Robert-Guroff
Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques.
Vaccine 2006;24(23):5064-72.
2006: Igor M Belyakov; Vladimir Kuznetsov; Brian Kelsall; Dennis M Klinman; Marcin Moniuszko; Michael Lemon; Phillip D Markham; Ranajit Pal; John Clements; Mark G Lewis; Warren Strober; Genoveffa Franchini; Jay A Berzofsky
Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.
Blood 2006;107(8):3258-64.
2006: Ranajit Pal; David Venzon; Sampa Santra; Vaniambadi S Kalyanaraman; David C Montefiori; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Janos Nacsa; Yvette Edghill Spano; Marcin Moniuszko; Zdenek Hel; Igor M Belyakov; Jay A Berzofsky; Robyn Washington Parks; Phillip D Markham; Norman L Letvin; Jim Tartaglia; Genoveffa Franchini
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
Journal of virology 2006;80(8):3732-42.
2006: Zdenek Hel; Wen-Po Tsai; Elzbieta Tryniszewska; Janos Nacsa; Phillip D Markham; Mark G Lewis; George Pavlakis; Barbara K Felber; Jim Tartaglia; Genoveffa Franchini
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(1):85-96.
2004: Sampa Santra; Dan H Barouch; Birgit Korioth-Schmitz; Carol I Lord; Georgia R Krivulka; Faye Yu; Margaret H Beddall; Darci A Gorgone; Michelle A Lifton; Ayako Miura; Valerie Philippon; Kelledy Manson; Phillip D Markham; John Parrish; Marcelo J Kuroda; Joern schmitz; Rebecca Gelman; John W Shiver; David C Montefiori; Dennis Panicali; Norman L Letvin
Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(30):11088-93.
2004: L Jean Patterson; Nina Malkevitch; David Venzon; Joel Pinczewski; V Raúl Gómez-Román; Liqun Wang; Vaniambadi S Kalyanaraman; Phillip D Markham; Frank A Robey; Marjorie Robert-Guroff
Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.
Journal of virology 2004;78(5):2212-21.
2003: Jun Zhao; Joel Pinczewski; V Raúl Gómez-Román; David Venzon; Vaniambadi S Kalyanaraman; Phillip D Markham; Kristine Aldrich; Matthew Moake; David C Montefiori; Yuanmei Lou; George Pavlakis; Marjorie Robert-Guroff
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
Journal of virology 2003;77(15):8354-65.
2002: Bo Peng; Rebecca Voltan; Lulu Lim; Yvette Edghill Spano; Sanjay Phogat; Dimiter S Dimitrov; Kamalpreet Arora; Michel Leno; Soe Than; ruth woodward; Phillip D Markham; Martin Cranage; Marjorie Robert-Guroff
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.
Journal of virology 2002;76(12):6016-26.
2002: Patricia L Earl; Linda S Wyatt; David C Montefiori; Miroslawa Bilska; ruth woodward; Phillip D Markham; James D Malley; Thorsten U Vogel; Todd M Allen; David Ian Watkins; Nancy Miller; Bernard Moss
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Virology 2002;294(2):270-81.
2002: Ranajit Pal; David Venzon; Norman L Letvin; Sampa Santra; David C Montefiori; Neil R Miller; Elzbieta Tryniszewska; Mark G Lewis; Thomas C VanCott; Vanessa M Hirsch; ruth woodward; A Gibson; M Grace; E Dobratz; Phillip D Markham; Zdenek Hel; Janos Nacsa; M Klein; Jim Tartaglia; Genoveffa Franchini
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Journal of virology 2002;76(1):292-302.
2001: Igor M Belyakov; Zdenek Hel; Brian Kelsall; Vladimir Kuznetsov; Jeffrey D Ahlers; Janos Nacsa; David Ian Watkins; Todd M Allen; A Sette; John D Altman; ruth woodward; Phillip D Markham; John Clements; Genoveffa Franchini; Warren Strober; Jay A Berzofsky
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
Nature medicine 2001;7(12):1320-6.
2001: L Jean Patterson; Frank A Robey; A Muck; K Van Remoortere; Kristine Aldrich; Ersell Richardson; W Gregory Alvord; Phillip D Markham; Martin Cranage; Marjorie Robert-Guroff
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.
AIDS research and human retroviruses 2001;17(9):837-49.
2000: L Jean Patterson; Bo Peng; Alash'Le Abimiku; Kristine Aldrich; L Murty; Phillip D Markham; Vaniambadi S Kalyanaraman; W Gregory Alvord; Jim Tartaglia; Genoveffa Franchini; Marjorie Robert-Guroff
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
AIDS (London, England) 2000;14(16):2445-55.
2000: JW Romano; RN Shurtliff; E Dobratz; A Gibson; K Hickman; Phillip D Markham; Ranajit Pal
Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.
Journal of virological methods 2000;86(1):61-70.
1999: S L Buge; L Murty; Kamalpreet Arora; Vaniambadi S Kalyanaraman; Phillip D Markham; E S Richardson; Kristine Aldrich; L Jean Patterson; Christopher J Miller; S M Cheng; Marjorie Robert-Guroff
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
Journal of virology 1999;73(9):7430-40.
1999: Michel Leno; L Carter; D J Venzon; J Romano; Phillip D Markham; K Limbach; Jim Tartaglia; E Paoletti; J Benson; Genoveffa Franchini; Marjorie Robert-Guroff
CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
AIDS research and human retroviruses 1999;15(5):461-70.
1998: Marjorie Robert-Guroff; H Kaur; L Jean Patterson; Michel Leno; Anthony J Conley; PM McKenna; Phillip D Markham; Ersell Richardson; Kristine Aldrich; Kamalpreet Arora; L Murty; L Carter; Susan Zolla-Pazner; F Sinangil
Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.
Journal of virology 1998;72(12):10275-80.
1998: F Samaniego; Phillip D Markham; R Gendelman; Y Watanabe; Vivian Kao; K Kowalski; Joseph Sonnabend; A Pintus; Robert C Gallo; Barbara Ensoli
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
The American journal of pathology 1998;152(6):1433-43.
1998: Valeria Fiorelli; R Gendelman; Maria Caterina Sirianni; H K Chang; S Colombini; Phillip D Markham; paolo monini; Joseph Sonnabend; A Pintus; Robert C Gallo; Barbara Ensoli
gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
Blood 1998;91(3):956-67.
1997: MD Lubeck; Robert J Natuk; M Myagkikh; Narender Kalyan; Kristine Aldrich; F Sinangil; S Alipanah; S C Murthy; P K Chanda; S M Nigida; Phillip D Markham; Susan Zolla-Pazner; K Steimer; M Wade; Marvin Reitz; L O Arthur; S Mizutani; A Davis; P P Hung; Robert C Gallo; J Eichberg; Marjorie Robert-Guroff
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.
Nature medicine 1997;3(6):651-8.
1997: F Samaniego; Phillip D Markham; R Gendelman; Robert C Gallo; Barbara Ensoli
Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1887-94.
1996: M Myagkikh; S Alipanah; Phillip D Markham; Jim Tartaglia; E Paoletti; Robert C Gallo; Genoveffa Franchini; Marjorie Robert-Guroff
Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
AIDS research and human retroviruses 1996;12(11):985-92.
1995: Paolo Lusso; Fiorenza Cocchi; Claudia Balotta; Phillip D Markham; A Louie; P Farci; R Pal; Robert C Gallo; Marvin Reitz
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
Journal of virology 1995;69(6):3712-20.
1995: F Samaniego; Phillip D Markham; Robert C Gallo; Barbara Ensoli
Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(7):3582-92.
1995: Alash'Le Abimiku; Genoveffa Franchini; Jim Tartaglia; Kristine Aldrich; M Myagkikh; Phillip D Markham; P Chong; M Klein; M P Kieny; E Paoletti
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.
Nature medicine 1995;1(4):321-9.
1995: Valeria Fiorelli; R Gendelman; F Samaniego; Phillip D Markham; Barbara Ensoli
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
The Journal of clinical investigation 1995;95(4):1723-34.
1994: Alash'Le Abimiku; T L Stern; A Zwandor; Phillip D Markham; C Calef; S Kyari; W C Saxinger; Robert C Gallo; Marjorie Robert-Guroff; Marvin Reitz
Subgroup G HIV type 1 isolates from Nigeria.
AIDS research and human retroviruses 1994;10(11):1581-3.
1994: jason smythe; D Sun; M Thomson; Phillip D Markham; Marvin Reitz; Robert C Gallo; Julianna Lisziewicz
A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3657-61.
1992: Marjorie Robert-Guroff; Kristine Aldrich; RR Muldoon; T L Stern; Geetha P Bansal; T J Matthews; Phillip D Markham; Robert C Gallo; Genoveffa Franchini
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
Journal of virology 1992;66(6):3602-8.
1991: Paolo Lusso; M Malnati; Andrea De Maria; Claudia Balotta; S E DeRocco; Phillip D Markham; Robert C Gallo
Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(2):685-91.
1991: A Hosmalin; PL Nara; M Zweig; N W Lerche; Kemp B Cease; E A Gard; Phillip D Markham; S D Putney; M D Daniel; R C Desrosiers
Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(5):1667-73.
1990: Paolo Lusso; Phillip D Markham; S E DeRocco; Robert C Gallo
In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo.
Journal of virology 1990;64(6):2751-8.
1989: Paolo Lusso; Robert C Gallo; S E DeRocco; Phillip D Markham
CD4 is not the membrane receptor for HHV-6.
Lancet 1989;1(8640):730.
1989: Paolo Lusso; Barbara Ensoli; Phillip D Markham; Dharam V Ablashi; S Z Salahuddin; Erwin Tschachler; F Wong-Staal; Robert C Gallo
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.
Nature 1989;337(6205):370-3.
1989: Dharam V Ablashi; Paolo Lusso; C L Hung; S Z Salahuddin; S F Josephs; T Llana; B Kramarsky; P Biberfeld; Phillip D Markham; Robert C Gallo
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).
Developments in biological standardization 1989;70():139-46.
1988: Dharam V Ablashi; Paolo Lusso; C L Hung; S Z Salahuddin; S F Josephs; T Llana; B Kramarsky; P Biberfeld; Phillip D Markham; Robert C Gallo
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).
International journal of cancer. Journal international du cancer 1988;42(5):787-91.
1988: S Nakamura; S Z Salahuddin; P Biberfeld; Barbara Ensoli; Phillip D Markham; F Wong-Staal; Robert C Gallo
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
Science (New York, N.Y.) 1988;242(4877):426-30.
1988: S Z Salahuddin; S Nakamura; P Biberfeld; Mark H Kaplan; Phillip D Markham; L Larsson; Robert C Gallo
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.
Science (New York, N.Y.) 1988;242(4877):430-3.
1988: Paolo Lusso; Phillip D Markham; Annamari Ranki; Patricia L Earl; Bernard Moss; F Dorner; Robert C Gallo; KJ Krohn
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2467-73.
1988: Paolo Lusso; Phillip D Markham; Erwin Tschachler; F di Marzo Veronese; S Z Salahuddin; Dharam V Ablashi; Savita Pahwa; K Krohn; Robert C Gallo
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).
The Journal of experimental medicine 1988;167(5):1659-70.
1987: Paolo Lusso; S Z Salahuddin; Dharam V Ablashi; Robert C Gallo; F Di Marzo Veronese; Phillip D Markham
Diverse tropism of HBLV (human herpesvirus 6)
Lancet 1987;2(8561):743.
1987: S Z Salahuddin; Dharam V Ablashi; E A Hunter; M A Gonda; S Sturzenegger; Phillip D Markham; Robert C Gallo
HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
International journal of cancer. Journal international du cancer 1987;39(2):198-202.
1987: Dharam V Ablashi; S Sturzenegger; E A Hunter; A G Palestine; L S Fujikawa; M K Kim; Robert B Nussenblatt; Phillip D Markham; S Z Salahuddin
Presence of HTLV-III in tears and cells from the eyes of AIDS patients.
Journal of experimental pathology 1987;3(4):693-703.
1986: S Z Salahuddin; Dharam V Ablashi; Phillip D Markham; S F Josephs; S Sturzenegger; Mark H Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.
Science (New York, N.Y.) 1986;234(4776):596-601.
1985: S H Weiss; W C Saxinger; D Rechtman; M H Grieco; J Nadler; S Holman; H M Ginzburg; J E Groopman; James J Goedert; Phillip D Markham
HTLV-III infection among health care workers. Association with needle-stick injuries.
JAMA : the journal of the American Medical Association 1985;254(15):2089-93.
1985: F di Marzo Veronese; M G Sarngadharan; R Rahman; Phillip D Markham; M Popovic; A J Bodner; Robert C Gallo
Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(15):5199-202.
1985: Robert R Redfield; Phillip D Markham; S Z Salahuddin; M G Sarngadharan; A J Bodner; Thomas M Folks; W Ripley Ballou; D C Wright; Robert C Gallo
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.
JAMA : the journal of the American Medical Association 1985;253(11):1571-3.